Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus ...

This year’s updated Covid-19 vaccines have been approved by the US Food and Drug Administration for adults 65 and older and ...

The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...

Morning. Today, we examine the plush pay packages of health care’s top CEOs in 2024. Also, we discuss Stealth BioTherapeutics ...

When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some financial analysts said the buyout amounted to an out-of-court ...

BioNTech, and Novavax targeting the LP.8.1 sublineage of SARS-CoV-2, with eligibility limited to adults aged 65 years and ...

GSK will receive a payout of $370 million after a settlement was reached between CureVac, BioNTech, and Pfizer in a dispute over mRNA vaccine technology. The UK-based pharma company will also receive ...

Cambridge-based rejuvenation biology company developing therapies to reverse ageing and extend healthspan, has fortified its leadership team with a key hire. The company has brought in former BioNTech ...

WASHINGTON (AP) — US regulators approved Pfizer’s updated COVID-19 shot Wednesday but with limits that could complicate ...